摘要:
A benzodiazepine derivative of formula I, or a pharmaceutically acceptable salt thereof: wherein
(a) R 1 is -CH 2 CHOH(CH 2 ) a R 4 or a ketone group -CH 2 CO(CH 2 ) a R 5 in which a is 0 or 1 and R 4 and R 5 are selected from alkyl groups of up to 8 carbon atoms; (b) R 2 and R 3 are independently selected from optionally substituted monocyclic aromatic carbocylic and heterocyclic residues of 5 or 6 ring atoms of which one, two or three may be heteroatoms, the optional substituents being selected from halogen atoms and hydroxy, amino, nitro, carboxylic acid, carboxamido and cyano groups and alkyl, alkoxy, alkylamino and dialkylamino groups in which the or each alkyl group is of up to 8 carbon atoms; and (c) W and X are selected independently from halogen and hydrogen atoms and C 1 -C 8 alkyl and C 1 -C 8 alkoxy groups.
These compounds are gastrin and/or CCK-B receptor antagonists.
摘要:
A benzodiazepine derivative of formula (I), or a pharmaceutically acceptable salt thereof, wherein (a) R1 is -CH¿2?CHOH(CH2)aR?4¿ or a ketone group -CH¿2?CO(CH2)aR?5¿ in which a is 0 or 1 and R?4 and R5¿ are selected from alkyl and cycloalkyl groups and saturated heterocyclic groups optionally substituted at a hetero-atom; (b) R?2 and R3¿ are independently selected from aromatic carbocyclic and heterocylic residues; and (c) W and X are selected independently from halogen and hydrogen atoms and alkyl and alkoxy groups. These compounds are gastrin and/or CCK-B receptor antagonists.
摘要:
L'invention concerne un dérivé de benzodiazépine de la formule (I) ou un sel pharmaceutiquement acceptable de celui-ci, dans laquelle: (a) R1 représente -CH2CHOH(CH2)aR4 ou un groupe cétone -CH2CO(CH2)aR5 dans lequel a est 0 ou 1 et R4 et R5 sont sélectionnés parmi des groupes alkyle et cycloalkyle, ainsi que parmi des groupes hétérocycliques saturés éventuellement substitués au niveau d'un hétéro-atome; (b) R2 et R3 sont indépendamment sélectionnés parmi des résidus carbocycliques et hétérocycliques aromatiques; et (c) W et X sont indépendamment sélectionnés parmi halogène et des atomes d'hydrogène, et parmi des groupes alkyle et alcoxy. Ces composés sont des antagonistes récepteurs de gastrine et/ou de CCK-B.
摘要:
A benzodiazepine derivative of formula (I), or a pharmaceutically acceptable salt thereof, wherein: (a) R4 is an alkyl, cycloalkyl or aryl group; (b) R10 is chosen from halo, OH, CH¿3?, OCH3, NR?11R12, NO¿2, NHCHO, CO2H and CN, and R?11 and R12¿ are independently selected from H and alkyl (C¿1?-C5) or together NR?11R12¿ form a cyclic structure (II), wherein a is 1-6; and (c) R2 is an aromatic 5- or 6-membered, substituted or unsubstituted heterocycle containing at least two heteroatoms of which at least one is nitrogen. These compounds are gastrin and/or CCK-B receptor antagonists.